SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 13.28 |
| Enterprise Value ($M) | -14.02 |
| Book Value ($M) | 53.04 |
| Book Value / Share | 6.91 |
| Price / Book | 0.25 |
| NCAV ($M) | 15.72 |
| NCAV / Share | 2.05 |
| Price / NCAV | 0.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.51 |
| Return on Assets (ROA) | 0.34 |
| Return on Equity (ROE) | 0.44 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.40 |
| Current Ratio | 4.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 32.88 |
| Assets | 70.19 |
| Liabilities | 17.15 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -6.52 |
| Net Income | 0.33 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -2.15 |
| Cash from Investing | -5.00 |
| Cash from Financing | -10.71 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Intracoastal Capital, Llc | 9.99 | -12.14 | |
| 13G | Ayrton Capital LLC | 9.90 | -45.38 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,246 | 11,441 | 19.63 | |
| 2,355 | 12,214 | 19.28 | |
| 835 | 5,658 | 14.76 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PHIO – Phio Pharmaceuticals Corp. | PIRS – Pieris Pharmaceuticals, Inc. |
| PLUR – Pluri Inc. | PMN – ProMIS Neurosciences, Inc. |
| PRFX – PainReform Ltd. |
Financial data and stock pages provided by
Fintel.io